Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis

Drug Metabolism and Disposition

Volumn 30, Issue 6, 2002, Pages 670-675

  Macha, Sreeraj ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; GANCICLOVIR; PHOSPHATE; PRODRUG; PROPIONIC ACID; SODIUM CHLORIDE; VALERIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG HYDROLYSIS; EYE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEAN RESIDENCE TIME; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTERS; GANCICLOVIR; MALE; MICRODIALYSIS; PRODRUGS; RABBITS; TISSUE DISTRIBUTION; VITREOUS BODY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036260024     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.6.670     Document Type: Article

References (40)

1. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus
2. Intravitreal ganciclovir pharmacokinetics in rabbits and man
3. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results
4. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immuno deficiency syndrome
5. Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression
6. Effect of mono- and di-acylation on the ocular disposition of ganciclovir. Physiochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs
7. Intravenous microdialysis sampling in awake, freely-moving rats
8. Cytomegalovirus infection in patients with AIDS
9. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir
10. Ganciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
11. A prospective study of the ophthalmologic findings in the acquired immunodeficiency syndrome
12. Regioselective synthesis of various prodrugs of ganciclovir
13. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogenic marrow transplant
14. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome
15. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS
16. Acquired immune deficiency syndrome: Ocular manifestations
17. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: A novel ocular microdialysis technique
18. Susceptibility of HCMV clinical isolates to ganciclovir and HPMPC
19. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: Implications for therapy
20. Ocular esterase composition in albino and pigmented rabbits: Possible implications in ocular prodrug design and evaluation
21. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits
22. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique
23. Ocular pharmacokinetics of cephalosporins using microdialysis
24. Microdialysis techniques in the study of brain and skeletal muscle
25. Susceptibility of human cytomegalovirus to two-drug combinations in vitro
26. Ganciclovir: An update of its therapeutic use in cytomegalo-virus infection
27. High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration
28. Comparative pharmacokinetics of antiviral nucleoside analogues
29. Management of cytomegalovirus infection in solid-organ transplant recipients
30. Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit
31. Microdialysis: A novel tool for research in the reproductive system
32. Pharmacokinetics of norfloxacin and lomefloxacin in domestic rabbit aqueous humor analysis by microdialysis
33. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro
34. Anti-herpes virus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
35. Antiviral activity of anticytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique
36. A removable ocular microdialysis system for measuring vitreous biogenic amines
37. Cytomegalovirus prophylaxis and treatment following bone marrow transplantation
38. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis
39. Intravitreal concentrations of some drugs administered with microdialysis
40. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogenic bone marrow transplant recipients: Results of a placebo-controlled, double-blind trial